Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 138 Records) |
Query Trace: Death and MET[original query] |
---|
PD-L1 Expression and Comprehensive Molecular Profiling Predict Survival in Nonsmall Cell Lung Cancer: A Real-World Study of a Large Chinese Cohort. Clinical lung cancer 2021 Aug . Jin Yan, Xue Qianqian, Shen Xuxia, Zheng Qiang, Chen Haiquan, Zhou Xiaoyan, Li Yu |
Verification of Single Nucleotide Polymorphisms rs34554140, rs6670279, and rs6874185 as Novel Molecular Genetic Markers of Sudden Cardiac Death. Sovremennye tekhnologii v meditsine 2021 9 13 (2): 40-44. Ivanova A A, Gurazheva A A, Melnikova E S, Nesterets A M, Malyutina S K, Rodina I A, Maksimov V |
Association of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic Leukemia. JAMA oncology 2021 Aug . Mangum David Spencer, Meyer Julia A, Mason Clinton C, Shams Soheil, Maese Luke D, Gardiner Jamie D, Downie Jonathan M, Pei Deqing, Cheng Cheng, Gleason Adam, Luo Minjie, Pui Ching-Hon, Aplenc Richard, Hunger Stephen P, Loh Mignon, Greaves Mel, Trede Nikolaus, Raetz Elizabeth, Frazer J Kimble, Mullighan Charles G, Engel Michael E, Miles Rodney R, Rabin Karen R, Schiffman Joshua |
Clinical and genetic factors associated with anxiety and depression in breast cancer patients: a cross-sectional study. BMC cancer 2021 Jul 21 (1): 872. Hajj Aline, Hachem Roula, Khoury Rita, Hallit Souheil, ElJEBBAWI Bashar, Nasr Fady, El Karak Fadi, Chahine Georges, Kattan Joseph, Rabbaa Khabbaz Lyd |
A retrospective analysis of eleven gene mutations, PD-L1 expression and clinicopathological characteristics in non-small cell lung cancer patients. Asian journal of surgery 2021 Jul . Liu Yanqing, Wu Aihua, Li Xinjian, Wang Shanshan, Fang Shuyu, Mo Yij |
The genomic characteristics of different progression patterns in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors. Annals of translational medicine 2021 7 9 (9): 779. Li Jingwen, Xiang Chan, Wang Yue, Zhou Yan, Cao Shuhui, Ling Xuxinyi, Ye Junyi, Zheng Jingjing, Shao Lin, Zhong Hua, Han Yuch |
Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma. Cancers 2021 11 13 (22): . Terai Mizue, Shimada Ayako, Chervoneva Inna, Hulse Liam, Danielson Meggie, Swensen Jeff, Orloff Marlana, Wedegaertner Philip B, Benovic Jeffrey L, Aplin Andrew E, Sato Taka |
Optimal Treatments for NSCLC Patients Harboring Primary or Acquired MET Amplification. Technology in cancer research & treatment 2022 9 21 15330338221128414. Sun Dantong, Tao Junyan, Yan Weihua, Zhu Jingjuan, Zhou Hai, Sheng Yingying, Xue Chaofan, Li Hong, Hou Hel |
Pyrotinib combined with apatinib for targeting metastatic non-small cell lung cancer with HER2 alterations: a prospective, open-label, single-arm phase 2 study (PATHER2). BMC medicine 2022 8 20 (1): 277. Yang Guangjian, Xu Haiyan, Yang Yaning, Zhang Shuyang, Xu Fei, Hao Xuezhi, Li Junling, Xing Puyuan, Hu Xingsheng, Liu Yutao, Wang Lin, Lin Lin, Wang Zhijie, Duan Jianchun, Wang Jie, Wang Y |
A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib. BMC medical genomics 2022 Jun 15 (1): 141. Chen Yan, Jiang Bo, He Yuange, Zhang Chu, Zhou Wenjie, Fang Cheng, Gu Dejian, Zhang Minxia, Ji Mei, Shi Juntao, Yang X |
Molecular and clinicopathological analysis revealed an immuno-checkpoint inhibitor as a potential therapeutic target in a subset of high-grade myxofibrosarcoma. Virchows Archiv : an international journal of pathology 2022 Jun . Yamashita Atsushi, Suehara Yoshiyuki, Hayashi Takuo, Takagi Tatsuya, Kubota Daisuke, Sasa Keita, Hasegawa Nobuhiko, Ishijima Muneaki, Yao Takashi, Saito Tsuyos |
Correlative analysis of gene mutation and clinical features in patients with non-small cell lung cancer. Translational cancer research 2022 2 8 (3): 736-751. Kuang Xiao, Xiao Jian, Dai Long-Xia, Zhang Li-Hai, He Bi-X |
Treatment Response to Immunotherapy After Crizotinib Resistance in a Patient With Pulmonary Sarcomatoid Carcinoma Harboring MET Exon 14 Skipping Mutation: A Case Report. Clinical Medicine Insights. Oncology 2022 2 16 11795549211067185. Gu Ling, Wei Xiaoying, Zhang Zixiang, Heng W |
MET gene alterations predict poor survival following chemotherapy in patients with advanced cancer. Pathology oncology research : POR 2022 12 28 1610697. Ko Jihoon, Jung Jaeyun, Kim Seung Tae, Hong Jung Yong, Park Sehhoon, Park Joon Oh, Park Young Suk, Lim Ho Yeong, Ahn Soomin, Kim Kyoung-Mee, Kang Won Ki, Lee Jeey |
Clinical significance of intrarenal vascular lesions in non-hypertensive patients with IgA nephropathy. Journal of nephrology 2022 12 . Huang Ziyuan, Hu Ya, Chen Bo, Liang Yan, Li Duo, Qiu Wenxian, Zhang Ji, Chen Chaoshe |
Association of buccal micronucleus cytome assay (BMNCyt) biomarkers with inorganic element concentration and genetic polymorphisms in welders. Environmental toxicology and pharmacology 2022 12 97 104025. Quintana-Sosa Milton, León-Mejía Grethel, Narváez Diana M, Suarez-Arnedo Alejandra, Restrepo Helena Groot de, De Moya Yurina Sh, Ruiz-Benitez Martha, Valencia Karen Franco, Trindade Cristiano, Miranda-Guevara Alvaro, Dias Johnny, Henriques João Antonio Pêgas, da Silva Julia |
Tislelizumab Versus Docetaxel in Patients With Previously Treated Advanced NSCLC (RATIONALE-303): A Phase 3, Open-Label, Randomized Controlled Trial. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2022 10 18 (1): 93-105. Zhou Caicun, Huang Dingzhi, Fan Yun, Yu Xinmin, Liu Yunpeng, Shu Yongqian, Ma Zhiyong, Wang Ziping, Cheng Ying, Wang Jie, Hu Sheng, Liu Zhihua, Poddubskaya Elena, Disel Umut, Akopov Andrey, Dvorkin Mikhail, Zheng Wenjuan, Ma Yiyuan, Wang Yan, Li Songzi, Yu Cunjing, Rivalland Gare |
PD-L1 Expression in Chinese Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): A Multi-Center Retrospective Observational Study. Journal of Cancer 2022 1 12 (24): 7390-7398. Yang Xin, Jiang Lili, Jin Yan, Li Peng, Hou Yingyong, Yun Jingping, Wu Chunyan, Sun Wenyong, Fan Xiangshan, Kuang Dong, Wang Weiya, Ni Jinsong, Mao Anhua, Tang Wenmin, Liu Zhenhua, Wang Jiali, Xiao Suijun, Li Yuan, Lin Dongm |
Utility of multigene panel next-generation sequencing in routine clinical practice for identifying genomic alterations in newly diagnosed metastatic nonsmall cell lung cancer. Internal medicine journal 2023 9 . Udit Nindra, Abhijit Pal, Victoria Bray, Po Y Yip, Annette Tognela, Tara L Roberts, Therese M Becker, Jonathon Williamson, Mahtab Farzin, Jing J Li, Vivienne Lea, Abeer Hagelamin, Weng Ng, Bin Wang, C Soon Lee, Wei Ch |
Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial. The Lancet. Oncology 2023 9 . Fred Saad, Noel W Clarke, Mototsugu Oya, Neal Shore, Giuseppe Procopio, João Daniel Guedes, Cagatay Arslan, Niven Mehra, Francis Parnis, Emma Brown, Friederike Schlürmann, Jae Young Joung, Mikio Sugimoto, Oliver Sartor, Yu-Zhen Liu, Christian Poehlein, Laura Barker, Paula Michelle Del Rosario, Andrew J Armstro |
Compromised Outcomes in Stage IV Non-Small-Cell Lung Cancer With Actionable Mutations Initially Treated Without Tyrosine Kinase Inhibitors: A Retrospective Analysis of Real-World Data. JCO oncology practice 2023 8 OP2200611. Jeffrey A Scott, Jochen Lennerz, Melissa Lynne Johnson, Lucio N Gordan, Robert H Dumanois, Luca Quagliata, Lauren L Ritterhouse, Federico Cappuzzo, Brandon Wang, Mei Xue, Anupama Vasudevan, Prateesh Varughese, Varun Vaidya, Mike Gart, Natalie Dorrow, Hinco J Gierman, Rushir J Chok |
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC. The New England journal of medicine 2023 6 . Masahiro Tsuboi, Roy S Herbst, Thomas John, Terufumi Kato, Margarita Majem, Christian Grohé, Jie Wang, Jonathan W Goldman, Shun Lu, Wu-Chou Su, Filippo de Marinis, Frances A Shepherd, Ki Hyeong Lee, Nhieu Thi Le, Arunee Dechaphunkul, Dariusz Kowalski, Lynne Poole, Ana Bolanos, Yuri Rukazenkov, Yi-Long Wu, |
A systematic review of genetic ancestry as a risk factor for incidence of non-small cell lung cancer in the US. Frontiers in genetics 2023 4 14 1141058. Breanna A James, Jennie L Williams, Barbara Nemesu |
TERT promoter mutations in head and neck squamous cell carcinoma: A systematic review and meta-analysis on prevalence and prognostic significance. Oral oncology 2023 4 140 106398. Paolo Boscolo-Rizzo, Giancarlo Tirelli, Jerry Polesel, Egidio Sia, Veronica Phillips, Daniele Borsetto, Anita De Rossi, Silvia Giun |
Determinants of widespread metastases and of metastatic tropism in patients with prostate cancer: A genomic analysis of primary and metastatic tumors. Urologic oncology 2023 4 . Alshalalfa Mohammed, Goglia Alexander G, Swami Nishwant, Nguyen Bastien, Hougen Helen Y, Khan Anwar, Kishan Amar U, Punnen Sanoj, Nguyen Paul L, Mahal Brandon A, Dee Edward Christoph |
Clopidogrel Use in CYP2C19 Loss-of-Function Carriers With High Bleeding Risk After Percutaneous Coronary Intervention. Circulation journal : official journal of the Japanese Circulation Society 2023 2 . Sawayama Yuichi, Tomita Yukinori, Kohyama Soji, Higo Yosuke, Kodama Kenji, Asada Kohei, Yagi Noriaki, Fukuyama Megumi, Hayashi Atsushi, Shioyama Wataru, Sakai Hiroshi, Ozawa Tomoya, Isono Tetsuichiro, Hira Daiki, Yamamoto Takashi, Morita Shin-Ya, Nakagawa Yoshihi |
PDL1 and molecular biomarkers expression in non-small cell lung cancer in Tunisian patients. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 2023 11 . Yoldez Houcine, Chirine Moussa, Ahmed Ben Abdelaziz, Aida Aya |
Determining the prognosis of Lung cancer from mutated genes using a deep learning survival model: a large multi-center study. Cancer cell international 2023 11 23 (1): 262. Jie Peng, Lushan Xiao, Hongbo Zhu, Lijie Han, Honglian |
Effect of genotype on individual response to the pharmacological treatment of glaucoma: a systematic review and meta-analysis. Biology direct 2023 10 18 (1): 66. Damiana Scuteri, Giulio Pocobelli, Yoichi Sakurada, Rossella Russo, Paolo Tonin, Pierluigi Nicotera, Giacinto Bagetta, Maria Tiziana Corasaniti, Carlo Nuc |
Effectiveness and safety of amivantamab in EGFR exon 20 insertion (E20I) mutations in non-small cell lung cancer (NSCLC). Translational lung cancer research 2024 1 12 (12): 2448-2459. Dae-Ho Choi, Hyun Ae Jung, Sehhoon Park, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Se-Hoon L |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: